Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04718220 · ClinicalTrials.gov registry record · NA
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
NCT04718220 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 448 participants.
The verdict
NCT04718220, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
Study Summary
Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine optimal testing strategies by evaluating the necessity of testing for asymptomatic disease in pregnancy, inform prenatal care plans by assessing the full impact of infection, and contribute to a provider's ability to counsel women and create prenatal care plans if they are pregnant or considering pregnancy.
Interventions
- DIAGNOSTIC_TEST Antibody testing for SARS-CoV-2 IgG
- DIAGNOSTIC_TEST Testing for SARS-CoV-2 RNA
- DIAGNOSTIC_TEST Testing for SARS-CoV-2 IgM/IgG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04718220
The ClinicalTrials.gov registry entry for NCT04718220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 448 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Antibody testing for SARS-CoV-2 IgG is the first listed.
NCT04718220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04718220 about?
NCT04718220 is a clinical study titled "Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19". Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine op...
What is the current status of trial NCT04718220?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2021-03-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04718220?
The interventions under investigation include: Antibody testing for SARS-CoV-2 IgG (DIAGNOSTIC_TEST), Testing for SARS-CoV-2 RNA (DIAGNOSTIC_TEST), Testing for SARS-CoV-2 IgM/IgG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04718220?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.